Disintegration Time Limit Test in the Chinese Pharmacopoeia: Principles, Apparatus, and Acceptance C

The disintegration test defined in the Chinese Pharmacopoeia (ChP General Chapter 0921) is a core quality control procedure that verifies whether oral solid dosage forms break apart within specified time limits under physiological-like conditions. This article provides a comprehensive technical overview of the ChP disintegration time limit test, covering the apparatus, media, methodology, acceptance criteria, and practical applications for tablets, capsules, and pills.

Technical Overview

The disintegration time limit test is one of the most widely performed quality control tests for oral solid dosage forms in the Chinese pharmaceutical industry. It is described in General Chapter 0921 of the Chinese Pharmacopoeia, which is published under the authority of the National Medical Products Administration (NMPA) and compiled by the Chinese Pharmacopoeia Commission. The current 2020 edition of the pharmacopoeia places this general chapter in Volume IV, which contains general test methods applicable to all monographs.

The purpose of the test is to determine whether a dosage form, such as a tablet, capsule, or pill, breaks down into small fragments or particles within a defined period when exposed to an aqueous medium at body temperature. Disintegration is a critical prerequisite for drug absorption: a solid dosage form must first disintegrate before the active pharmaceutical ingredient can dissolve and become bioavailable. The test therefore serves as a simple, rapid, and reproducible screening tool for batch release, formulation development, and stability evaluation.

The test uses a lifting-type basket-rack assembly that oscillates vertically through an aqueous medium maintained at 37 degrees Celsius. The assembly holds six transparent glass tubes, each closed at the bottom by a stainless steel wire mesh with approximately 2.0 mm openings. Unless otherwise specified, six dosage units are tested individually, one in each tube. The basket moves up and down at a frequency of 30 to 35 cycles per minute through a vertical travel of approximately 55 mm, ensuring continuous agitation and contact between the dosage unit and the medium.

Complete disintegration is defined as the state in which the dosage unit passes entirely through the mesh, leaving no solid residue except insoluble fragments of coating material. A small amount of soft residue that does not pass through the mesh is still acceptable provided it has no palpably firm core and can be easily deformed. It is important to emphasize that the disintegration test measures the physical breakdown of the dosage form, not the rate or extent of drug dissolution, which is evaluated separately by the dissolution test.

Testing Samples

Tablets

Tablets are the largest category of products subject to the disintegration test. The Chinese Pharmacopoeia distinguishes among several tablet types, each with its own time limit and, in some cases, its own test conditions. These include uncoated compressed tablets, film-coated tablets, sugar-coated tablets, enteric-coated tablets, colon-targeted enteric tablets, orodispersible tablets, sublingual tablets, and effervescent tablets. The coating type and intended site of release in the gastrointestinal tract determine both the test medium and the acceptance criterion.

Capsules

Both hard capsules and soft capsules are tested using the basket-rack assembly. Capsules may float on the surface of the medium, in which case a smooth perforated plastic disc is placed on top of each unit to keep it submerged and to aid contact with the liquid. Enteric-coated capsules follow a two-stage procedure analogous to enteric-coated tablets, first in an acidic medium and then in a phosphate buffer.

Pills and Drop Pills

Traditional Chinese medicine pills and modern drop pills are also evaluated for their breakdown behavior. Small pills and drop pills are typically tested on the same lifting-type apparatus, with the test being described as a scattering or dissolution time requirement. Drop pills generally must disintegrate within 30 minutes, while coated drop pills are allowed up to 60 minutes, unless the individual monograph specifies otherwise. Large honey pills are normally exempt because of their intended slow-release character.

Dosage Forms Not Covered

Modified-release products, such as sustained-release and controlled-release tablets, are generally not subjected to the conventional disintegration test, because their design intentionally delays breakdown. For these products, dissolution testing is the primary performance indicator. Similarly, lozenges designed for slow dissolution in the mouth may be exempt or governed by monograph-specific requirements.

Testing Items

The core testing item is the complete disintegration of each dosage unit within the time limit stated in the individual monograph or in the general chapter. Unless otherwise specified, the standard time limits in the Chinese Pharmacopoeia are as follows:

• Uncoated tablets: complete disintegration within 15 minutes.
• Film-coated tablets: complete disintegration within 30 minutes.
• Sugar-coated tablets: complete disintegration within 60 minutes.
• Enteric-coated tablets: no cracking, softening, or disintegration after 120 minutes in 0.1 mol/L hydrochloric acid, followed by complete disintegration within 60 minutes in pH 6.8 phosphate buffer.
• Colon-targeted enteric tablets: must remain intact through the acid stage and the pH 6.8 buffer stage, and then disintegrate within one hour in a higher-pH buffer as defined in the monograph.
• Orodispersible tablets: complete disintegration within 60 seconds.
• Sublingual tablets: complete disintegration within 5 minutes.
• Effervescent tablets: must release gas and disintegrate within 5 minutes in 200 mL of water at 15 to 25 degrees Celsius, leaving no agglomerated particles.
• Hard capsules: complete disintegration within 30 minutes.
• Soft capsules: complete disintegration within 60 minutes.
• Drop pills: complete disintegration within 30 minutes, or 60 minutes for coated drop pills.

In addition to the time limit itself, the test evaluates the physical integrity of enteric products during the acid stage, the visible gas evolution of effervescent products, and the absence of a firm, undispersed core in any residue retained on the mesh. These observations form part of the formal acceptance decision.

Testing Methods

Apparatus Preparation and Operating Parameters

The disintegration tester consists of a thermostatic water bath, a motorized drive unit, and a removable basket-rack assembly suspended from a metal rod. Before testing, the operator must confirm that the bath temperature is maintained at 37 degrees Celsius plus or minus 1 degree, that the reciprocating frequency is 30 to 35 strokes per minute, and that the vertical travel of the assembly is approximately 55 mm. The wire mesh must be clean and free of trapped air bubbles, and the liquid level must be adjusted so that the assembly remains fully immersed and does not contact the bottom of the vessel at the lowest point of the stroke.

Test Media

Unless otherwise directed by the monograph, water is used as the default medium. Individual monographs may specify alternatives that simulate physiological conditions, including:

• Water for standard immediate-release tablets and capsules.
• Hydrochloric acid solution, equivalent to approximately 0.1 mol/L, for the acid stage of enteric-coated products.
• Phosphate buffer at pH 6.8 for the buffer stage of enteric-coated products.
• Simulated gastric fluid or simulated intestinal fluid where the monograph requires them, with or without enzymes as specified.

General Test Procedure

The standard procedure proceeds as follows:

• Bring the medium to 37 degrees Celsius plus or minus 1 degree and verify all apparatus parameters.
• Place one dosage unit in each of the six glass tubes, taking care not to damage coating layers.
• If the units float, add a suitable perforated plastic disc to each tube.
• Immerse the basket-rack assembly and immediately start the timer and the oscillation.
• Observe the units throughout the run and record the time at which each unit completely disintegrates.
• Inspect the mesh at the endpoint for any retained residue and assess whether it is soft and core-free or represents a genuine failure.

Acceptance Criteria and Retesting

The acceptance logic in the Chinese Pharmacopoeia follows a two-stage design. In the first stage, six dosage units are tested, and all six must disintegrate completely within the specified time. If exactly one unit fails, a second stage is performed with six additional units, and all six units in the retest must pass. If two or more units fail in the first stage, or if any unit fails in the retest, the batch does not meet the requirement. This staged approach balances statistical confidence with practical testing burden.

Special Procedures

Effervescent tablets are tested differently: one tablet is placed in a beaker containing 200 mL of water at 15 to 25 degrees Celsius without basket agitation, and the operator observes vigorous gas evolution followed by dissolution or dispersion of the tablet within 5 minutes. Enteric-coated products require sequential exposure: after the acid stage, the assembly is transferred to the pH 6.8 buffer, or the medium is replaced, and the test continues without resetting the acceptance criteria of the first stage.

Applications

The disintegration test is applied throughout the product life cycle in both commercial and research settings. Its principal applications include:

• Batch release testing of tablets, capsules, and pills against pharmacopoeial and registered specifications.
• Formulation development, where disintegration time guides the selection of disintegrants, binders, fillers, and coating systems.
• Process validation and scale-up studies, linking compression force, granulation method, and coating parameters to product performance.
• Stability programs, where slowing disintegration during storage signals physical aging, moisture uptake, or coating degradation.
• Regulatory submissions to the NMPA and post-approval change assessments, including site transfers and formulation modifications.
• Comparative studies with international pharmacopoeias such as the USP, EP, and JP, since the basket-rack method is largely harmonized across major compendia, supporting global product supply.

For traditional Chinese medicine products, the test also supports consistency evaluation of extraction, concentration, and pill-forming operations, ensuring that herbal preparations release their multi-component contents in a predictable manner.

FAQ

Which chapter of the Chinese Pharmacopoeia governs the disintegration test?

General Chapter 0921, Disintegration Test, in Volume IV of the Chinese Pharmacopoeia. Individual product monographs may impose stricter limits or specify particular media, and the monograph requirement always takes precedence.

Does disintegration mean the drug has been released?

No. Disintegration only confirms that the dosage form physically breaks apart into fragments. Actual release of the active ingredient is governed by dissolution and must be demonstrated by the dissolution test, particularly for poorly soluble drugs and modified-release products.

What happens if one of the six tablets fails to disintegrate in time?

If exactly one of the six units fails, a retest with six additional units is performed, and all six retest units must disintegrate within the limit. Failure of two or more units initially, or any failure in the retest, results in non-compliance.

Why are enteric-coated products tested in two stages?

Enteric coatings are designed to protect the drug or the stomach from gastric acid and to release the drug in the intestine. The acid stage verifies that the coating resists 0.1 mol/L hydrochloric acid for two hours, and the buffer stage at pH 6.8 verifies that the product then disintegrates within one hour, mimicking transit into the small intestine.

Is the disintegration test applicable to sustained-release tablets?

Generally no. Sustained-release and controlled-release formulations are intentionally designed for slow breakdown, so their performance is evaluated by multi-point dissolution profiles rather than by the conventional disintegration time limit.

How is the test kept reproducible between laboratories?

Reproducibility depends on strict control of bath temperature at 37 degrees Celsius plus or minus 1 degree, stroke frequency of 30 to 35 cycles per minute, clean and bubble-free mesh, correct liquid level, and consistent use of discs for floating capsules. Regular instrument qualification and adherence to the pharmacopoeial procedure are essential for reliable results.